Log in or Sign up for Free to view tailored content for your specialty!
Vasculitis and Giant Cell Arteritis News
Ultrasound halo present in giant cell arteritis at baseline, diminishes with treatment
A halo present on arterial segments was seen in patients with newly diagnosed giant cell arteritis, but the marker diminished after 7 days of treatment with glucocorticoids.
Study results show cocaine-induced vasculitis is clinically distinct
Clinical manifestations of cocaine-induced vasculitis differed distinctively from non-cocaine induced vasculitis, according to research presented at the American College of Rheumatology Annual Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
EULAR 2006 criteria insufficient for diagnosing HSP in patients with vasculitis
The European League Against Rheumatism 2006 criteria for diagnosing Henoch-Schönlein purpura in patients with primary cutaneous vasculitis showed poor concordance with previous sets of classification criteria, according data presented at the American College of Rheumatology conference in Boston.
VIDEO: Challenges in vasculitis care shows where researchers should focus
In this video, Fahmeedah Kamal, MD, highlights challenges in vasculitis and what research can do to address them.
VIDEO: Provider, patient education equally critical for vasculitis management
In this video, Fahmeedah Kamal, MD, speaks with Healio about how education plays a role in vasculitis awareness.
VIDEO: Counsel patients with vasculitis about pregnancy risks early in disease course
In this video, Fahmeedah Kamal, MD, speaks with Healio about vasculitis and pregnancy management.
VIDEO: ‘Collaboration is key’ for managing patients with vasculitis
In this video, Fahmeedah Kamal, MD, discusses the role of collaborative care in the management of patients with vasculitis.
VIDEO: Research in ANCA-associated vasculitis may bring a ‘big change in practice’
In this video, Fahmeedah Kamal, MD, discusses a current hot topic in vasculitis research.
VIDEO: ‘Rapidly evolving’ treatment landscape in IgG4-related disease
John H. Stone, MD, MPH, professor of medicine at Harvard Medical School, the Edward A. Fox Chair in Medicine at Massachusetts General Hospital, spoke with Healio about available treatment options for IgG4-related disease.
VIDEO: ‘Highly treatable’ IgG4-related disease ‘rewarding’ to diagnose
In this video, John H. Stone, MD, MPH, professor of medicine at Harvard Medical School, the Edward A. Fox Chair in Medicine at Massachusetts General Hospital, discusses an important facet of IgG4-related disease other rheumatologists and providers should be aware of.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read